185 related articles for article (PubMed ID: 36857354)
1. Contribution of labor related gene subtype classification on heterogeneity of polycystic ovary syndrome.
Zhou J; Jiang Z; Fu L; Qu F; Dai M; Xie N; Zhang S; Wang F
PLoS One; 2023; 18(3):e0282292. PubMed ID: 36857354
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome: Identification of novel and hub biomarkers in the autophagy-associated mRNA-miRNA-lncRNA network.
Huang J; Huang B; Kong Y; Yang Y; Tian C; Chen L; Liao Y; Ma L
Front Endocrinol (Lausanne); 2022; 13():1032064. PubMed ID: 36523600
[TBL] [Abstract][Full Text] [Related]
3. Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome.
Chen Y; Ma L; Ge Z; Pan Y; Xie L
Front Mol Biosci; 2022; 9():888194. PubMed ID: 35693550
[No Abstract] [Full Text] [Related]
4. Identification of Hub Genes and Biomarkers between Hyperandrogen and Normoandrogen Polycystic Ovary Syndrome by Bioinformatics Analysis.
Zhang T; Liu Y; Li X; Hu B
Comb Chem High Throughput Screen; 2023; 26(1):126-134. PubMed ID: 35379124
[TBL] [Abstract][Full Text] [Related]
5. Explore the potential molecular mechanism of polycystic ovarian syndrome by protein-protein interaction network analysis.
Chen Q; Zheng B; Du S; Lin Y
Taiwan J Obstet Gynecol; 2021 Sep; 60(5):807-815. PubMed ID: 34507653
[TBL] [Abstract][Full Text] [Related]
6. The lncRNA-miRNA-mRNA ceRNA network in mural granulosa cells of patients with polycystic ovary syndrome: an analysis of Gene Expression Omnibus data.
Chen H; Cheng S; Xiong W; Tan X
Ann Transl Med; 2021 Jul; 9(14):1156. PubMed ID: 34430597
[TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome.
Qiao G; Xing J; Luo X; Zhang C; Yi J
Endocrine; 2022 Dec; 78(3):615-627. PubMed ID: 36068422
[TBL] [Abstract][Full Text] [Related]
8. Identification and immune features of cuproptosis-related molecular clusters in polycystic ovary syndrome.
Su Z; Su W; Li C; Ding P; Wang Y
Sci Rep; 2023 Jan; 13(1):980. PubMed ID: 36653385
[TBL] [Abstract][Full Text] [Related]
9. Exploration of hub genes involved in PCOS using biological informatics methods.
Zhou F; Xing Y; Cheng T; Yang L; Ma H
Medicine (Baltimore); 2022 Oct; 101(40):e30905. PubMed ID: 36221354
[TBL] [Abstract][Full Text] [Related]
10. Identification of the similarly expressed genes in patients with polycystic ovary syndrome and transsexuals.
Dong R; Gao S; Shan MJ
Medicine (Baltimore); 2021 Sep; 100(35):e26990. PubMed ID: 34477128
[TBL] [Abstract][Full Text] [Related]
11. Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis.
Dapas M; Lin FTJ; Nadkarni GN; Sisk R; Legro RS; Urbanek M; Hayes MG; Dunaif A
PLoS Med; 2020 Jun; 17(6):e1003132. PubMed ID: 32574161
[TBL] [Abstract][Full Text] [Related]
12. WGCNA Analysis Identifies Polycystic Ovary Syndrome-Associated Circular RNAs That Interact with RNA-Binding Proteins and Sponge miRNAs.
Li M; Zeng Z; Zhang A; Ye Q; Su S; Xia T
Int J Gen Med; 2021; 14():8737-8751. PubMed ID: 34849014
[TBL] [Abstract][Full Text] [Related]
13. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.
Devarbhavi P; Telang L; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
Reprod Biol Endocrinol; 2021 Feb; 19(1):31. PubMed ID: 33622336
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics-based analysis of potential therapeutic target genes for polycystic ovary syndrome.
Liu Y; Yu J; Li J; Li W; Ma H
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):169-175. PubMed ID: 38678611
[TBL] [Abstract][Full Text] [Related]
15. Prediction of shared gene signatures and biological mechanisms between polycystic ovary syndrome and asthma: Based on weighted gene coexpression network analysis.
Bai L; Gao X; Guo Y; Gong J; Li Y; Huang H; Liu X
Int J Gynaecol Obstet; 2024 Apr; 165(1):155-168. PubMed ID: 38055328
[TBL] [Abstract][Full Text] [Related]
16. Identification of Crucial lncRNAs, miRNAs, mRNAs, and Potential Therapeutic Compounds for Polycystic Ovary Syndrome by Bioinformatics Analysis.
Zeng Z; Lin X; Xia T; Liu W; Tian X; Li M
Biomed Res Int; 2020; 2020():1817094. PubMed ID: 33224973
[TBL] [Abstract][Full Text] [Related]
17. Identification of key genes and miRNAs related to polycystic ovary syndrome by comprehensive analysis of microarray.
Sun Z; Wang Y; Wei T; Liu L
BMC Med Genomics; 2022 Dec; 15(1):267. PubMed ID: 36544152
[TBL] [Abstract][Full Text] [Related]
18. Investigating the active components of Huatan Tongjing decoction for the treatment of polycystic ovary syndrome via network pharmacology.
Yu J; Fu Y; Zeng L; Zheng Y
Chem Biol Drug Des; 2022 Oct; 100(4):515-524. PubMed ID: 35822313
[TBL] [Abstract][Full Text] [Related]
19. Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.
Wu T; Gao YY; Tang XN; Li Y; Dai J; Zhou S; Wu M; Zhang JJ; Wang SX
Hum Reprod; 2022 Nov; 37(12):2856-2866. PubMed ID: 36223608
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics Analysis of ceRNA Network Related to Polycystic Ovarian Syndrome.
Li Y; Tan Y
Comput Math Methods Med; 2021; 2021():9988347. PubMed ID: 34211581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
